Fluoresentric Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B

Fluoresentric General Information

Description

Developer of technology and devices used in healthcare. The company provides assay design, optimization, and custom manufacturing services for the healthcare and biotechnology sector.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Medical Supplies
Primary Office
  • P.O. Box 983037
  • Park City, UT 84098
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluoresentric Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 10-Feb-2015 00000 Completed Generating Revenue
1. Debt - General 08-Sep-2014 00000 00000 Completed Generating Revenue
To view Fluoresentric’s complete valuation and funding history, request access »

Fluoresentric Patents

Fluoresentric Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3402595-A1 Systems, apparatus, and methods for inline sample preparation Pending 11-Jan-2016 000000000000
EP-3402595-A4 Systems, apparatus, and methods for inline sample preparation Pending 11-Jan-2016 000000000000 0
US-20190168219-A1 Systems, apparatus, and methods for inline sample preparation Pending 11-Jan-2016 000000000000
EP-3349903-A1 Apparatus, systems and methods for dynamic flux amplification of samples Pending 16-Sep-2015 00000000
EP-3349903-A4 Apparatus, systems and methods for dynamic flux amplification of samples Pending 16-Sep-2015 B01L7/52 0
To view Fluoresentric’s complete patent history, request access »

Fluoresentric Executive Team (4)

Name Title Board Seat Contact Info
Lynda Merrill Chief Executive Officer
Brian Caplin Ph.D Founder & Chief Science Officer
You’re viewing 2 of 4 executive team members. Get the full list »